| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Rituximab versus cyclophosphamide for ANCA-associated vasculitis. | N Engl J Med | 2010 | 11.05 |
| 2 | Efficacy of remission-induction regimens for ANCA-associated vasculitis. | N Engl J Med | 2013 | 5.67 |
| 3 | Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. | Ann Rheum Dis | 2012 | 1.01 |
| 4 | Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis. | Arthritis Rheum | 2011 | 0.96 |
| 5 | Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis. | PLoS One | 2012 | 0.80 |
| 6 | HIV type 2 primary isolates induce a lower degree of apoptosis "in vitro" compared with HIV type 1 primary isolates. | AIDS Res Hum Retroviruses | 2004 | 0.80 |